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Abstract The aim of the present study was to evaluate 
the expression of two high affinity GABA transporters 
(GAT-1 and GAT-3) in the rat cerebellum using immuno- 
cytochemistry and affinity purified antibodies. GAT-1 
immunoreactivity was prominent in punctate structures 
and axons in all layers of the cerebellar cortex, and was 
especially prominent around the somata of Purkinje 
cells. In contrast, the deep cerebellar nuclei showed few 
if any GAT-1 immunoreactive puncta. Weak GAT-3 im- 
munoreactive processes were present in the cerebellar 
cortex, whereas GAT-3 immunostaining was prominent 
around the somata of neurons in the deep cerebellar nu- 
clei. Electron microscopic preparations of the cerebellar 
cortex demonstrated that GAT-1 immunoreactive axon 
terminals formed symmetric synapses with somata, axon 
initial segments and dendrites of Purkinje cells and the 
dendrites of granule cells. Astrocytic processes in the 
cerebellar cortex were also immunolabeled for GAT-1. 
However, Purkinje cell axon terminals that formed sym- 
metric synapses with neurons in the deep cerebellar nu- 
clei lacked GAT-1 immunoreactivity. Instead, weak GAT- 
1 and strong GAT-3 immunoreactivities were expressed 
by astrocytic processes that enveloped the Purkinje cell 
axon terminals. In addition, GAT-3-immunoreactivity ap-
peared in astrocytic processes in the cerebellar cortex. 
These observations demonstrate hat GAT-1 is localized 
to axon terminals of three of the four neuronal types that 
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were previously established as being GABAergic, i.e. 
basket, stellate and Golgi cells. GAT-1 and GAT-3 are 
expressed by astrocytes. The failure to identify a GABA 
transporter in Purkinje cells is consistent with previous 
data that indicated that Purkinje cells lacked terminal up- 
take mechanisms for GABA. The individual glial envel- 
opment of Purkinje cell axon terminals in the deep cere- 
bellar nuclei and the dense immunostaining of GAT-3, 
and to a lesser extent GAT-1, expressed by astrocytic 
processes provide a compensatory mechanism for the re- 
moval of GABA from the synaptic cleft of synapses 
formed by Purkinje cell axon terminals. 
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Introduction 
The Purkinje cells of the cerebellum are probably the 
first well-documented GABAergic inhibitory neurons in 
the mammalian brain (Eccles et al. 1967; Chan-Palay 
1977). In addition to Purkinje cells, three other cerebel- 
lar cortical neurons - basket, stellate and Golgi cells, 
were described as having immunoreactivity for the 
GABA-synthesizing enzyme, glutamate decarboxylase 
(GAD; McLaughlin et al. 1974; Saito et al. 1974; Ribak 
et al. 1978; Oertel et al. 1981). Subsequent studies 
showed that all four cell types express GAD and 7-ami- 
nobutyric acid (GABA; Oertel et al. 1981; Seguela et al. 
1984; Ottersen et al. 1987). GABAergic neurons have 
subsequently been identified by immunocytochemical 
and in situ hybridization methods (Greif et al. 1991). 
Thus, the presence of GAD and GABA in Purkinje cells 
confirmed the physiological and pharmacological find- 
ings that indicated these neurons were GABAergic. 
In the past 25 years, some doubt has been raised 
about Purkinje cells being GABAergic because they did 
not take up 3H-GABA when it was placed into the cere- 
bellar cortex, deep cerebellar nuclei or vestibular nuclei 
(H6kfelt and Ljungdahl 1970; Kelly and Dick 1976; Tol- 
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bert and Bantli  1980; Wik lund et al. 1983). In contrast, 
3H-GABA placed into the cerebel lar cortex resulted in 
the label ing of basket, stellate and Golgi  cells (H6kfelt 
and Ljungdahl  1970, 1972; Schon and Iversen 1972; 
Chan-Palay 1977; Tolbert and Bantl i  1980). These stud- 
ies indicated that Purkinje cells lack a GABA carrier that 
can take up GABA from the extracel lular space. 
Recently, four GABA transporters, GAT-1, GAT-2, 
GAT-3 and a betaine glycine transporter (BGT-1), have 
been cloned and found to be expressed in brain (Guastel-  
la et al. 1990; Borden et al. 1992; Clark et al. 1992; 
Lopez-Corcuera et al. 1992; Brecha and Weigmann 
1993, 1994; Liu et al. 1993; Durkin et al. 1995). Al l  four 
of the transporters take up GABA in a Na § and C1- de- 
pendent manner, and they share a high degree of predict- 
ed amino acid sequence identity (Guastel la et al. 1990; 
Borden et al. 1992) Specif ic polyclonal  antibodies to the 
GATs have been used in immunocytochemical  studies to 
determine their tissue distr ibution and cel lular local iza- 
tion. GAT-1 is found predominant ly in neurons (Clark et 
al. 1992; Brecha and Weigmann 1994; Ikegaki et al. 
1994; Minel l i  et al. 1995; Johnson et al. 1996; R ibak et 
al. 1996). GAT-2 is found in ependymal  cells, whereas 
GAT-3 is predominant ly  expressed in astrocytes (Ikegaki 
et al. 1994; Durkin et al. 1995; Johnson et al. 1996; 
Ribak et al. 1996). Specif ic affinity purif ied antibodies to 
GAT-1 and GAT-3 were used in the present study to de- 
termine their cel lular local ization in the cerebel lum. The 
results indicate that the axon terminals of three of the 
four GABAerg ic  cerebel lar neurons contain GAT-1 
whereas those of the Purkinje cells lack GABA trans- 
porters. In addition, the astrocytic processes that envelop 
the axon terminals of  Purkinje cells are densely labeled 
for GAT-3 and to a lesser extent GAT-1. 
Methods and materials 
Animals 
Adult albino rats (Sprague-Dawley; Harlan, San Diego, Calif.), 
weighing 180-250 g were used in these studies. They were fed 
and housed under regular conditions. Care and handling of ani- 
mals were approved by the Animal Research Committees of the 
University of California t Irvine and the VAMC-West Los Ange- 
les in accordance with all NIH guidelines. 
Antibodies 
Affinity purified, polyclonal antibodies directed to GAT-1 (346J) 
and GAT-3 (369D) were used in these studies (Minelli et al. 1995, 
1996; Johnson et al. 1996; Ribak et al. 1996). The GAT-1 antibody 
is directed to the last 12 amino acids of the predicted C-terminus 
of rat GAT-1 (GAT-1288499). The GAT-3 antibody is directed to the 
last 21 amino acids of the predicted C-terminus of rat GAT-3 
(GAT-3607_627). These antibodies were affinity purified using either 
an Epoxy-Sepharose-GAT-1588 99 or an Epoxy-Sepharose- GAT- 
3607_627 affinity column (Pharmica Biotech, Piscataway, N.J.). 
The specificity of the immunostaining in the cerebellum was 
demonstrated by the lack of immunostaining in sections when us- 
ing: (a) preimmune serum in place of the primary antibodies, (b) 
the GAT-1 antibody which was preadsorbed overnight with 10 _2 M 
GAT-1288_599, (c) the GAT-3 antibody which was preadsorbed 
overnight with 10 -5 M GAT-3607_627. In addition, the pattern of 
GAT-1 immunostaining was unchanged when the primary anti- 
body was preadsorbed overnight with 10 -5 M rat GAT-2594_602, rat 
GAT-3607_627 or rat glycine transporter-1625_633 (GLYT-1622_633) 
(Guastella et al. 1990, 1992; Borden et al. 1992). Finally, the pat- 
tern of GAT-3 immunostaining was unchanged when the primary 
antibody was preadsorbed with 10 -5 M rat GAT-1588 599, rat GAT- 
2594_602 or rat GLYT- 1625_633. 
Immunocytochemistry; light microscopy 
Rats were anesthetized with Nembutal (100 mg/kg) and perfused 
through the heart with 0.12 M PBS (pH 7.4) followed by 4% para- 
formaldehyde (PFA) in 0.12 M phosphate buffer at pH 7.4. The 
brain was removed and postfixed in 4% PFA in 0.12 M phosphate 
buffer at 4~ overnight. Sections were cut at 50 gm in the parasag- 
ittal plane with a vibratome and stored in 0.12 M phosphate buffer 
for immunocytochemical processing. 
Tissue sections containing the cerebellum were washed in 
0.12 M phosphate buffer, incubated in 10% normal goat serum in 
0.12 M PBS for 1 h and washed again. The sections were incubat- 
ed in antibodies directed to GAT-1588 599 (1:500-1:2000) or GAT- 
3607_627 (1:1000) in 0.12 M PBS with 0.5% Triton X-100 and 10% 
normal goat serum overnight at 4~ The sections were washed, 
incubated in biotinylated goat anti-rabbit IgG (Vector Laborato- 
ries, Burlingame, Calif.) at a dilution of 1:200 in l% normal goat 
serum and 0.12 M PBS for 1 day at 4~ The sections were 
washed, incubated in an avidin-biotin peroxidase mixture (Vecta- 
stain ABC Kit, Vector Laboratories) for 1 day at 4~ The sections 
were then washed, incubated in 0.5% 3,3-diaminobenzidine tetra- 
hydrochloride (DAB; Sigma) in 0.01% H20 2 for 15-20 rain. The 
sections were washed, mounted onto gelatin-coated slides, dehy- 
drated and coverslipped. 
Immunocytochemistry; electron microscopy 
Rats were anesthetized with Nembutal (100 mg/kg) and perfused 
with 0.1 M PBS (pH 7.4), followed by 200 ml of 4% PFA and 
0.1% glutaraldehyde in 0.12 M phosphate buffer at pH 7.4. The 
brains were removed and placed in 4% PFA solution overnight at 
4~ The next day, brains were removed from PFA and sectioned 
in the parasagittal plane with a vibratome at 50 gin. 
Sections containing the cerebellum were rinsed with 0.12 M 
PBS for 15 rain before they were immersed in 10% normal goat 
serum in 0.12 M PBS. The sections were then placed in GAT-1 or 
GAT-3 antibodies and incubated overnight at 4~ The primary an- 
tibody was diluted 1:1000 with 10% normal goat serum and 0.5% 
Triton X-100. The sections were washed three times in 0.1 M PBS 
for 15 rain in each rinse. All subsequent washings of sections were 
carried out following this same procedure. Sections were incubat- 
ed in biotinylated goat anti-rabbit IgG at a dilution of 1:200 and 
1% normal goat serum in 0.1 M PBS for 1 h at room temperature. 
After rinsing the sections in PBS, they were incubated in ABC 
complex solution for 1 h. The ABC complex was prepared by 
mixing 1% Avidin DH and 1% biotinylated enzyme with 0.1% 
Triton X-100 in PBS at pH 7.5. The sections were thoroughly 
washed before being incubated in 0.5% DAB solution diluted with 
0.01% H20 2 in 0.1 M PBS for 20 min. Finally, the sections were 
removed and rinsed. 
These sections were osmicated with cold (4~ 1% OsO 4 for 
30 rain, dehydrated in graded ethanol, and embedded in Medcast. 
Semithin 2-gin sections were cut from these blocks for light mi- 
croscopic analysis, i.e., photographed and examined to identify the 
cerebellar cortex and deep cerebellar nuclei. Also, the layers in the 
cerebellar cortex were mapped for orientation of the thin sections 
in the transmission electron microscope. Ultrathin sections were 
cut on a Sorvall MT-5000 microtome, collected on Formvar coated 
slot grids, stained with lead citrate and uranyl acetate and exam- 
ined with a Philips CM-10 electron microscope. 
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Results 
Light microscopic localization of GAT-1 and GAT-3 
Cerebellar cortex 
The distribution of GAT-1 immunolabeling was similar 
to that described previously for GAD (Saito et al. 1974). 
GAT-1 positive puncta surrounded the somata of Purkin- 
je cells (Fig. 1). Purkinje cells also had several puncta 
associated with the basal portion of their soma, the so- 
called pinceau region (Palay and Chan-Palay 1974). In 
addition, GAT-1 immunolabeled puncta and fibers were 
present in the molecular layer. The granule cell layer dis- 
played GAT-1 puncta interspersed between the granule 
cells. 
The light microscopic distribution of GAT-3 in the 
cerebellar cortex was much different. Small GAT-3 punc- 
ta were found randomly scattered in the three layers 
(Fig. 1). There were no clusters of GAT-3 puncta along 
the surfaces of Purkinje cells. 
Deep cerebellar nuclei 
formed symmetric synapses with the axon initial seg- 
ment in any one thin section. Small labeled axon termi- 
nals were found in the deeper parts of the granule cell 
layer where they formed symmetric synapses with den- 
drites of granule cells that were also postsynaptic to 
mossy fibers (not shown). 
The GAT-1 positive axon terminals in the molecular 
layer formed symmetric synapses with dendritic shafts 
(Fig. 3A,B). Some of the dendrites were of large diame- 
ter and arose from Purkinje cells. Smaller dendrites were 
also postsynaptic to labeled axon terminals and these lat- 
ter dendrites may arise from basket, stellate or Golgi 
cells. In the inner molecular layer, GAT-1 positive axon 
terminals also formed axosomatic symmetric synapses 
with small somata that had morphological features of 
basket cells (Fig. 3C). 
GAT-3 immunolabeling in the cerebellar cortex was 
found in astrocytic processes in all of the layers (Fig. 4). 
The labeling for GAT-3 positive profiles was sparse and 
so was that for GAT-1 in the deep cerebellar nuclei. 
GAT-3 immunolabeted profiles occurred in the neuropil 
near, but not adjacent, to axon terminals forming sym- 
metric synapses. 
GAT-1 positive immunolabeling was sparse in the deep 
cerebellar nuclei (Fig. 1). Only a few small puncta were 
found. They were not concentrated along the surfaces of 
the neurons in this region. 
In contrast, GAT-3 immunolabeled puncta were con- 
centrated on the surfaces of neurons in the deep cerebel- 
lar nuclei (Fig. 1). The immunolabeling for GAT-3 con- 
tinued onto the surfaces of dendrites and outlined most 
of them. The white matter tracts approaching the deep 
cerebellar nuclei did not display immunolabeling. 
Electron microscopic localization of GAT- 1 and GAT-3 
Cerebellar cortex 
GAT-1 immunoreactivity was localized in axon terminals 
in all three layers of the cerebellar cortex (Figs. 2, 3). 
Also, small astrocytic processes displayed immunoreac- 
tion product for GAT-1. The labeled axon terminals in 
the Purkinje cell layer formed symmetric synapses with 
the somata of Purkinje cells (Fig. 2A,B). The reaction 
product was distributed heterogeneously in these axon 
terminals with dense accumulations associated with the 
plasma membrane and lighter labeling decorating synap- 
tic vesicles and mitochondria. The preterminal portions 
of these axon terminals also displayed immunoreaction 
product. 
Labeled axon terminals for GAT-1 were also present 
in the region of the axon initial segment of Purkinje cells 
in the granule cell layer (Fig. 2C). This region is called 
the "pinceau" (Palay and Chan-Palay 1974). Several im- 
munolabeled axons were found to run parallel with the 
axon initial segment. Only a few of these labeled axons 
Deep cerebellar nuclei 
The deep cerebellar nuclei were analyzed to determine 
whether the axon terminals of Purkinje cells express 
GAT-1. GAT-1 immunoreactivity was not observed in ax- 
on terminals that formed symmetric synapses with the 
dendrites and somata of neurons in the deep cerebellar 
nuclei (Fig. 5). Previous studies showed that most axon 
terminals from Purkinje cells form symmetric synapses 
in the deep cerebellar nuclei (Walberg et al. 1976). The 
only immunolabeling for GAT-1 in the deep cerebellar 
nuclei was in processes of astrocytes (Fig. 5). Some of 
these were found in close apposition to the unlabeled ax- 
on terminals that formed symmetric axosomatic and axo- 
dendritic synapses. 
GAT-3 immunolabeling was very prominent in the 
deep cerebellar nuclei. Very dense immunolabeling oc- 
curred in astrocytic processes that surrounded the Pur- 
kinje cell axon terminals that form symmetric axosomat- 
Fig. 1 Photomicrographs of semi-thin 2 btm sections of the cere- 9 
bellar cortex (A, B) and deep cerebellar nuclei (C, D). A Shows 
the immunopositive GAT-1 structures in the cerebella cortex. La- 
beled axons (arrowheads) appear in the molecular layer (M) where 
they contact a Purkinje cell dendrite (curved arrow). The somata 
of Purkinje cells (P) are outlined by GAT-1 labeled puncta (ar- 
rows), that are probably the axons of basket cells. The Purkinje 
cell on the right also shows immunolabeled axons in the pinceau 
region (large arrow). Only a few puncta are found in the granule 
cell layer (G). B, C Show sparse immunolabeling for GAT-3 in the 
cerebellar cortex, and GAT-1 in the deep cerebellar nuclei, respec- 
tively. C Shows two somata (d) of deep cerebellar neurons. D 
Shows strong immunolabeling (arrows) for GAT-3 around the 
somata of two deep cerebellar neurons (d). Nomarski optics. A 
xl,200, B xl,200, C xl,200, D xl,200 
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Fig. 1A-D 
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Fig. 2A-C 
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9 Fig. 2A-C GAT-1 immunolabeling of axon terminals in the Pur- 
kinje cell layer. A Shows an elongated GAT-l-immunopositive 
basket axon terminal that forms three symmetric synapses (ar- 
rows) with a soma (S) of a Purkinje cell located next to a capillary 
(Ca). A small endfoot process (p) of an astrocyte also displays im- 
munostaining for GAT-1. B Another example of a GAT-1 immuno- 
reactive axon terminal forming axosomatic synapses with a Pur- 
kinje cell. Note the three symmetric synapses (arrows). C Shows 
several GAT-1 labeled axon terminals (a) in the pinceau region of 
the axon initial segment (IS) of a Purkinje cell. A x43,000, B 
x42,000, C x28,000 
Fig. 3A-C GAT-1 immunolabeling of axon terminals in the mo- 
lecular layer of the cerebellar cortex. A Shows three GAT-1 immu- 
noreactive axon terminals that form symmetric synapses (arrows) 
with a medium-sized endrite (D). Note that one of the axon ter- 
minals has immunolabeling that continues into its preterminal seg- 
ment (PT). B Shows another GAT-1 positive axon terminal that 
forms a symmetric synapse (arrow) with a large dendrite from a 
Purkinje cell. Note the lamellar body (L) in the cytoplasm of the 
dendrite. C Shows a GAT-1 immunolabeled axon terminal that 
forms a symmetric synapse (arrow) with a soma (S) of a basket 
ceil located in the inner molecular layer. A,B x43,000, C x42,000 
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Fig. 4A-C GAT-3 immunolabeling in the granule cell layer of the 
cerebellar cortex. A Shows portions of a glomerulus where im- 
munonegative axon terminals of Golgi cells form symmetric syn- 
apses (arrows) with dendrites of granule cells. A portion of a so- 
ma (S) of a granule cell is also shown. B Shows an enlargement of
the synapse with one of these dendrites (D), the one on the right. 
Note that GAT-3 immunoreaction product is found in small pro- 
cesses (arrowheads) of astrocytes. C Shows an axon initial seg- 
ment (IS) of a Purkinje cell with several adjacent immunonegative 
axon terminals. GAT-3 immunolabeling is present in astrocytic 
processes (arrowheads). A x17,000, B x30,000, C x16,000 
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Fig. 5A-C GAT-1 immunolabeling in the deep cerebellar nuclei. 
A-C Show that axon terminals forming symmetric synapses (ar- 
rows) with somata (in A,B) or dendrites (C) of deep cerebellar 
neurons lack immunostaining for GAT-1. In contrast, small astro- 
cytic processes (arlvwheads) that are found near these terminals 
display GAT-1 immunoreaction product (Ca capillary). A 
x32,000, B x31,000, C x37,000 
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Fig. 6A-C GAT-3 immunolabeling of astrocytic processes (ar- 
rowheads) in the deep cerebellar nuclei. A-C Show several im- 
munonegative axon terminals that form symmetric synapses (ar- 
rows) with somata (A,B) and dendrites (C) and GAT-3 immuno- 
positive astrocytic processes (arrowheads) that envelop them. A 
x32,000, B x43,000, C x43,000 
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Fig. 7A-C GAT-3 immunolabeling of the perikaryal cytoplasm of 
astrocytes in deep cerebellar nuclei. A Show a fibrous astrocyte 
(F) in the white matter that contains GAT-3 imrnunoreaction prod- 
uct (asterisks). Note that the glial filaments (arrows) have no im- 
munolabeling associated with them. B An enlargement of the top 
portion of this astrocyte to show the GAT-3 immunolabeling (as- 
terisks) and glial filaments (arrow). C Shows a portion of a proto- 
plasmic astrocyte (P) with GAT-3 immunolabeling (asterisk). The 
glial filaments (arrow) show no immunolabeling. An adjacent so- 
ma (s) of a neuron is immunonegative. A x15,000, B x37,000, 
C x29,000 
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ic and axodendritic synapses (Fig. 6). The density of im- 
munoreaction product in these astrocytic processes with 
GAT-3 was greater than that for GAT-1 (Figs. 5, 6). The 
somata of astrocytes also displayed large amounts of 
GAT-3 immunoreaction product (Fig. 7). The labeling in 
the somata of astrocytes avoided the bundles of glial fila- 
ments in their cytoplasm (Fig. 7B). 
Discussion 
One of the major findings of this study is that GAT-1, 
and not GAT-3, is found in the axon terminals of three 
GABAergic cell types in the cerebellum, but not in the 
fourth type, the Purkinje cells. That is, axon terminals of 
basket cells forming symmetric axosomatic synapses 
with Purkinje cell bodies expressed GAT-1. Likewise, 
axon terminals of stellate and Golgi cells were also im- 
munopositive for GAT-1. These findings are consistent 
with results from a previous study of the cerebellar cor- 
tex using polyclonal antibodies to a partially purified 
GABA transporter (Radian et al. 1990). However, the 
present study showed that the axon terminals of Purkinje 
cells in the deep cerebellar nuclei appeared to lack im- 
munostaining for GAT-1. The lack of GAT-1 immunore- 
activity in Purkinje cells is consistent with previous data 
from in situ hybridization studies that showed little or no 
labeling for GAT-1 mRNA over Purkinje cells (Rattray 
and Priestley 1993; Durkin et al. 1995). This observation 
is also consistent with several previous studies that indi- 
cated Purkinje cells do not take up 3H-GABA into their 
cell bodies from their axon terminals (H6kfelt and 
Ljungdahl 1970, 1972; Schon and Iversen 1972; Kelly 
and Dick 1976; Chan-Palay 1977; Tolbert and Bantli 
1980; Wiklund et al. 1983). 
It is unclear why Purkinje cells do not express GAT-1 
or GAT-3. While GATs were demonstrated to exhibit 
Na + and C1- dependent, high affinity uptake for GABA 
in heterologous cell systems (Guastella et al. 1990; Bor- 
den et al. 1992; Clark et al. 1992), there is evidence that 
GABA transporters may also release GABA into the syn- 
aptic cleft and extracellular space in a Ca ++ independent, 
non-vesicular manner (Pin and Bockaert 1989; Levi and 
Raiteri 1993). Do certain GABAergic neurons require 
GAT-1 for neurotransmitter uptake because they are met- 
abolically more active and thus have a greater demand 
for GABA? Or do more active GABAergic neurons re- 
lease GABA via GAT-1 during increased activity, such as 
that found in epileptic foci (During et al. 1995)? The 
lack of GAT-1 in Purkinje cells may indicate that these 
neurons are not particularly active. In any event, it is 
clear that Purkinje cells do not possess the ability for up- 
take of GABA. 
Another major finding is that GAT-1 and GAT-3 are 
localized to astrocytic processes in the cerebellum. This 
result is consistent with the finding that Bergmann glial 
cells express GAT-1 mRNA in the cerebellar cortex and 
GAT-3 mRNA labeling occurs in glia in the deep cere- 
bellar nuclei (Rattray and Priestley 1993; Durkin et al. 
1995). The labeling of astrocytic processes in the cere- 
bellar cortex for GAT-1 was lighter than that for GAT-3 
in the deep cerebellar nuclei. 
In the deep cerebellar nuclei, the moderate xpression 
of GAT-1 and the prominent expression of GAT-3 by as- 
trocytes uggest that GABA released by Purkinje cell ax- 
on terminals is taken up by glial cells. Interestingly, not 
only were the astrocytic processes enveloping axon ter- 
minals more immunoreactive for GAT-3 than GAT-1, but 
the somata of astrocytes in the deep cerebellar nuclei 
were observed to be immunolabeled for GAT-3. The 
dense glial labeling for GAT-3 accentuated the unique 
envelopment of the Purkinje cell axon terminals by astro- 
cytic processes. This relationship was previously de- 
scribed by Chan-Palay (1977) who concluded that astro- 
cytes play a role in the isolation of synapses, a principle 
that has been generalized to many brain regions (Peters 
et al. 1991). The presence of GABA transporter in these 
glial processes and not in the Purkinje cell axon termi- 
nals that use GABA provides a functional meaning for 
this intimate glial relationship that is not found univer- 
sally in the brain. For example, GABAergic neurons in 
the substantia nigra are apposed to each other without in- 
tervening lia (Ribaket al. 1976). If these latter axon ter- 
minals possess GAT-1, then it would indicate that they 
do not have to rely on glia for the removal of GABA 
from the synaptic left. 
The Purkinje cells represent an interesting GABA- 
ergic neuronal type among those found in the cerebellar 
cortex. They are projection eurons with axon terminals 
that terminate upon neurons in the deep cerebellar nuclei 
and Deiters' nucleus. However, unlike the other GABA- 
ergic cell types, the Purkinje cell does not take up or 
retrogradely transport 3H-GABA (Tolbert and Bantli 
1980; Wiklund et al. 1983). Thus, Purkinje cells seem to 
lack the uptake mechanisms for GABA. These findings, 
together with our results and the results of others show 
Purkinje cells lack GAT-1, GAT-2 and GAT-3 immunore- 
activities and mRNAs (Radian et al. 1990; Rattray and 
Priestley 1993; Ikegaki et al. 1994; Swan et al. 1994; 
Durkin et al. 1995). This example of a GABAergic neu- 
ron that lacks GABA transporter does not appear to be 
unique in the brain; Rattray and Priestley (1993) showed 
that neurons in the inferior colliculus and the thalamic 
reticular nucleus do not express GAT-1 mRNA, even 
though there were neurons in these regions that ex- 
pressed high levels of GAD67 mRNA. It would be inter- 
esting to know whether the GABAergic neurons in these 
regions share any common functional properties with 
Purkinje cells. 
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